Verified peer comparison
AbbVie Inc. Common Stock vs AstraZeneca Financial Comparison
AbbVie Inc. Common Stock versus AstraZeneca using 2025 financials in USD.
Direct answer
AbbVie Inc. Common Stock and AstraZeneca are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Verified data
- AbbVie Inc. Common Stock Revenue
- 61,160,000,000 USD
- AstraZeneca Revenue
- 58,739,000,000 USD
- AbbVie Inc. Common Stock Operating income
- 20,091,000,000 USD
- AstraZeneca Operating income
- 13,743,000,000 USD